The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 3,720,000 | 3,000,000 | SH | SOLE | 3,000,000 | 0 | 0 | ||
ANNEXON INC | COM | 03589W102 | 62,402,432 | 8,703,268 | SH | SOLE | 8,703,268 | 0 | 0 | ||
ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | 19,935,818 | 2,011,687 | SH | SOLE | 2,011,687 | 0 | 0 | ||
ATEA PHARMACEUTICALS INC | COM | 04683R106 | 10,041,978 | 2,485,638 | SH | SOLE | 2,485,638 | 0 | 0 | ||
C4 THERAPEUTICS INC | COM STK | 12529R107 | 9,331,856 | 1,142,210 | SH | SOLE | 1,142,210 | 0 | 0 | ||
CABALETTA BIO INC | COM | 12674W109 | 27,592,230 | 1,617,364 | SH | SOLE | 1,617,364 | 0 | 0 | ||
DIANTHUS THERAPEUTICS INC | COM | 252828108 | 89,760,840 | 2,992,028 | SH | SOLE | 2,992,028 | 0 | 0 | ||
DISC MEDICINE INC | COM | 254604101 | 82,009,681 | 1,317,213 | SH | SOLE | 1,317,213 | 0 | 0 | ||
INVIVYD INC | COM | 00534A102 | 7,990,202 | 1,799,595 | SH | SOLE | 1,799,595 | 0 | 0 | ||
KYVERNA THERAPEUTICS INC | COM | 501976104 | 78,590,481 | 3,163,868 | SH | SOLE | 3,163,868 | 0 | 0 | ||
MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 52,605,545 | 196,995 | SH | SOLE | 196,995 | 0 | 0 | ||
MARINUS PHARMACEUTICALS INC | COM NEW | 56854Q200 | 12,596,155 | 1,393,380 | SH | SOLE | 1,393,380 | 0 | 0 | ||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 38,813,255 | 8,663,673 | SH | SOLE | 8,663,673 | 0 | 0 | ||
NAUTILUS BIOTECHNOLOGY INC | COM | 63909J108 | 5,880,000 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | N62509109 | 247,708,042 | 10,473,913 | SH | SOLE | 10,473,913 | 0 | 0 | ||
NEWAMSTERDAM PHARMA COMPANY | *W EXP 99/99/999 | N62509117 | 1,104,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
NURIX THERAPEUTICS INC | COM | 67080M103 | 16,646,236 | 1,132,397 | SH | SOLE | 1,132,397 | 0 | 0 | ||
NUVALENT INC | COM | 670703107 | 202,537,779 | 2,697,267 | SH | SOLE | 2,697,267 | 0 | 0 | ||
PHARVARIS N V | COM | N69605108 | 76,341,135 | 3,303,381 | SH | SOLE | 3,303,381 | 0 | 0 | ||
RAPID MICRO BIOSYSTEMS INC | CLASS A COM | 75340L104 | 8,181,523 | 8,434,560 | SH | SOLE | 8,434,560 | 0 | 0 | ||
SAVARA INC | COM | 805111101 | 72,535,976 | 14,565,457 | SH | SOLE | 14,565,457 | 0 | 0 | ||
SOLID BIOSCIENCES INC | COM NEW | 83422E204 | 53,740,632 | 4,034,582 | SH | SOLE | 4,034,582 | 0 | 0 | ||
SYROS PHARMACEUTICALS INC | COM NEW | 87184Q206 | 14,711,473 | 2,749,808 | SH | SOLE | 2,749,808 | 0 | 0 | ||
TANGO THERAPEUTICS INC | COM | 87583X109 | 22,967,744 | 2,892,663 | SH | SOLE | 2,892,663 | 0 | 0 | ||
X4 PHARMACEUTICALS INC | COM | 98420X103 | 23,512,940 | 16,915,784 | SH | SOLE | 16,915,784 | 0 | 0 | ||
XILIO THERAPEUTICS INC | COM | 98422T100 | 3,029,846 | 2,805,413 | SH | SOLE | 2,805,413 | 0 | 0 |